THERAPEUTIC CLASS

Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances

---

The ongoing outbreak of the recently emerged 2019 novel coronavirus (nCoV), which has seriously threatened global health security, is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. Despite the
burden of the disease worldwide, still, no licensed vaccine or any specific drug against 2019‐nCoV is available. Data from several countries show that few repurposed drugs using existing antiviral drugs have not (so far) been satisfactory and more recently
were proven to be even highly toxic

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Jubi-R
Avigan
Anti-infectives

Specific Detail Info

J Cell Physiol. 2020;1–12.

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment